# Intravenous Tirofiban Versus Thrombolysis Before Mechanical Thrombectomy in Stroke

Study · id `cardio:ct-nct05728333` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05728333](<https://clinicaltrials.gov/study/NCT05728333>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05728333

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1014 participants.

## Technical summary

Registry record NCT05728333. Randomized; double masking; primary purpose treatment. Start 2023-11-28 (actual); primary completion 2026-05-25 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 1014 participants (enrolled count; ClinicalTrials.gov record NCT05728333, source copy `cardio:ctgov-nct05728333-2026-09-14`, retrieved 2026-10-26)
- Started: 2023-11-28 (actual) (ClinicalTrials.gov record NCT05728333, source copy `cardio:ctgov-nct05728333-2026-09-14`, retrieved 2026-10-26)
- Primary completion: 2026-05-25 (actual) (ClinicalTrials.gov record NCT05728333, source copy `cardio:ctgov-nct05728333-2026-09-14`, retrieved 2026-10-26)
- Completion: 2026-05-25 (actual) (ClinicalTrials.gov record NCT05728333, source copy `cardio:ctgov-nct05728333-2026-09-14`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05728333, source copy `cardio:ctgov-nct05728333-2026-09-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05728333-2026-09-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Intravenous Tirofiban Versus Thrombolysis Before Mechanical Thrombectomy in Stroke
- Acronym: ADJUVANT
- Condition: Stroke, Acute Ischemic
- Intervention (Drug): Tirofiban
- Intervention (Drug): Thrombolysis
- Lead sponsor: Xinqiao Hospital of Chongqing
- Lead sponsor class: OTHER
- Collaborator: Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Xinqiao Hospital of Chongqing (`cardio:org-xinqiao-hospital-of-chongqing`)

## Provenance

Content hash: 9e6daa6c7a1b6e907d5039339075a087f7617fb3978c46ee37df0cadc0a9f422
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
